The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Environmental Risk Factors, 2021Pesticide Exposure, Systems Biology and Parkinson’s Disease
Study Rationale:
Pesticide exposure is among the most consistently and widely reported environmental risk factors for Parkinson’s disease (PD). However, research on specific pesticides in... -
Therapeutic Pipeline Program, 2021Dietary Interventions to Slow and Improve Parkinson’s Symptoms by Restructuring the Gut Microbiome and Decreasing Inflammation
Study Rationale:
There is a link between the gut and the brain in Parkinson’s disease (PD), and gut bacteria may play an important role. Gut bacteria they affect the bowel mucus barrier, produce... -
Environmental Risk Factors, 2021Environmental Risk Factors for Parkinson’s Disease in a Prospective Veteran Cohort
Study Rationale:
Parkinson’s disease may be caused by exposure to toxic substances in the environment, but few of these have been identified. One reason may be that scientists have studied the... -
Research Grant, 2021A New Target for Limiting the Spread of Toxic Alpha-Synuclein Aggregation and Preventing Neuronal Degeneration
Study Rationale:
The pathological hallmark of Parkinson’s disease (PD) is the widespread accumulation of cellular inclusions, called Lewy Bodies, composed of clumps of improperly folded alpha... -
Target Advancement Program, 2021Targeting the Neurovascular Unit to Prevent Dissemination and Progression of Parkinson’s Disease
Study Rationale:
The cells residing in the brain are physically separated from the blood stream by the blood-brain barrier, a specialized grouping of cells that reduces transfer from the blood... -
Access to Data and Biospecimens, 2021Assessing Inhibition of a Protein of the “Complement System” to Reduce Brain Inflammation and Neuronal Loss in People with Parkinson’s Disease
Study Rationale:
Inflammation contributes to the degeneration of neurons in the brains of people with Parkinson’s disease (PD). One of the molecules involved in this inflammatory...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.